Physician profile
Brandon Sohm
NPI 1114242997
$763.76
in general payments reported to CMS, 2019-2025
18 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $88.34 · 2024: $439 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $763.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $203.91 | 2024 | |
| Abbvie INC. | $94.54 | 2023-2025 | Vraylar |
| Merck Sharp & Dohme LLC | $65.09 | 2024-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Phathom Pharmaceuticals, INC. | $58.65 | 2024-2025 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $53.29 | 2024-2025 | Breztri, Airsupra |
| Genzyme Corporation | $47.19 | 2024-2025 | |
| Mimedx Group, INC. | $31.57 | 2024 | |
| Kerecis Limited | $31.27 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Hydrofera LLC | $24.42 | 2025 | Hydrofera Blue |
| Astellas Pharma US INC | $22.03 | 2023 | Xospata |
| Insulet Corporation | $21.59 | 2025 | Omnipod |
| Horizon Therapeutics Plc | $20.30 | 2023 | Krystexxa |
| Lilly USA, LLC | $16.73 | 2023 | Verzenio, Retevmo |
| Vertex Pharmaceuticals Incorporated | $15.34 | 2025 | |
| G1 Therapeutics, INC. | $15.27 | 2023 | Cosela |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $15.04 | 2024 | Gattex |
| Tonix Medicines, INC. | $14.11 | 2025 | Tonmya |
| Cequr Corporation | $13.42 | 2024 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Sohm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.